LILLE, FR — Lesaffre, an independent global player in fermentation and microorganisms, announced its acquisition of dsm-firmenich’s yeast extract business.

The two companies agreed to a multi-part collaboration in yeast derivatives, specifically within the savory ingredients space. Lesaffre will acquire dsm-firmenich’s yeast extract market organization and experience, which will enable production in Lesaffre’s global manufacturing network.

“This transaction completely fits in our strategy to become a true global specialist in yeast extracts and derivatives for the savory ingredients market,” said Brice-Audren Riché, CEO of Lesaffre. “The collaboration with dsm-firmenich will help us keep pace in an ever-progressing industry and allow us to expand our business by integrating great people and new in-house supply capabilities.”

The transaction is expected to close by the end of the year. Acquiring dsm-firmenich’s yeast extract processing technologies will enable Lesaffre to better serve customers in fermentation-based applications, enhance its current R&D expertise and broaden its range of high-quality products.